GLP 1

Binge eating disorder (BED) is the most common eating disorder in the United States, and it’s also the most misunderstood.

This article walks through the major studies that shape current BED clinical practice.

GLP-1 receptor agonists were originally developed to manage type 2 diabetes, but their remarkable weight loss effects have opened up an entirely new category…

GLP-1 receptor agonists have transformed weight management over the past several years, giving patients and providers a class of medications with the kind of…

For most people starting a GLP-1 medication like semaglutide or tirzepatide, the injection itself is one of the first things they want to get…

The idea of getting a prescription for a GLP-1 medication without setting foot in a doctor’s office still surprises some people. It shouldn’t. Telehealth…

The growth of the compounded GLP-1 market has brought something genuinely useful to patients who couldn’t otherwise afford semaglutide or tirzepatide. It has also…

If you’ve been researching GLP-1 medications like semaglutide or tirzepatide, you’ve probably come across the term “compounding pharmacy” more than once. It gets used…

For a lot of women, the 40s are when weight loss stops responding to the strategies that used to work. The same diet that…